ALAB vs FSLR

ALAB demonstrates strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and profitability. The company exhibits exceptional growth momentum with 91.8% YoY revenue growth and 83.6% earnings growth, supported by high margins (75.69% gross, 25.70% net) and a pristine balance sheet with negligible debt (Debt/Equity: 0.02). Despite a high valuation (P/E: 98.61), the intrinsic value estimate of $35.99 and Graham Number of $14.83 suggest significant upside potential if growth is sustained. However, recent insider selling and a bearish technical trend introduce near-term caution. Price trades at a 234.3% premium to fair value estimate ($35.99), limiting near-term upside from a valuation perspective.

FSLR exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a negligible Debt/Equity ratio of 0.07. While the current price of $197.25 is slightly above the Graham Number ($167.15), it trades at a significant discount to its growth-based intrinsic value of $412.12. The valuation is highly attractive with a Forward P/E of 8.09 and a PEG ratio of 0.50, suggesting the market is underpricing its earnings growth. Despite bearish insider sentiment and technical trends, the fundamental core is robust and undervalued.